Convelo Therapeutics

OverviewSuggest Edit

Convelo Therapeutics is a company that provides medicines focusing on the regenerative capacity of the central nervous system. It develops drugs to regenerate the protective myelin coating around nerve cells and restore function in patients with neurological disorders. The company focuses on multiple sclerosis, pediatric leukodystrophies, traumatic injury, and age-related pathologies such as Alzheimer’s.
TypePrivate
Founded2016
HQCleveland, OH, US
Websiteconvelotx.com

Locations

Convelo Therapeutics is headquartered in
Cleveland, United States

Location Map

Latest Updates

Employees (est.) (Apr 2021)19
Cybersecurity ratingAMore

Key People/Management at Convelo Therapeutics

Paul Tesar

Paul Tesar

Co-Founder, Director
Derrick Rossi

Derrick Rossi

President and Chief Executive Officer, Director
Samantha Stubblefield

Samantha Stubblefield

Director of Research
Bill Sanford

Bill Sanford

Chairman of the Board
Drew Adams

Drew Adams

Co-Founder and VP of Discovery, Director
Brad Lang

Brad Lang

VP of Research
Show more

Convelo Therapeutics Office Locations

Convelo Therapeutics has an office in Cleveland
Cleveland, OH, US (HQ)
BioEnterprise, 11000 Cedar Ave
Show all (1)

Convelo Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2016

Convelo Therapeutics total Funding

$9.8 m

Convelo Therapeutics latest funding size

$7.8 m

Time since last funding

3 years ago

Convelo Therapeutics investors

Convelo Therapeutics's latest funding round in August 2018 was reported to be $7.8 m. In total, Convelo Therapeutics has raised $9.8 m
Show all financial metrics

Convelo Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Convelo Therapeutics Online and Social Media Presence

Embed Graph

Convelo Therapeutics Frequently Asked Questions

  • When was Convelo Therapeutics founded?

    Convelo Therapeutics was founded in 2016.

  • Who are Convelo Therapeutics key executives?

    Convelo Therapeutics's key executives are Paul Tesar, Derrick Rossi and Samantha Stubblefield.

  • How many employees does Convelo Therapeutics have?

    Convelo Therapeutics has 19 employees.

  • Who are Convelo Therapeutics competitors?

    Competitors of Convelo Therapeutics include YiChang HEC ChangJiang Pharmaceutical, Yabao Pharmaceutical and CSL Behring.

  • Where is Convelo Therapeutics headquarters?

    Convelo Therapeutics headquarters is located at BioEnterprise, 11000 Cedar Ave, Cleveland.

  • Where are Convelo Therapeutics offices?

    Convelo Therapeutics has an office in Cleveland.

  • How many offices does Convelo Therapeutics have?

    Convelo Therapeutics has 1 office.